The global spine biologics market to grow at CAGR of 4.1% through 2022: 3 things to know

Written by Shayna Korol | May 29, 2018 | Print  |

The global spine biologics market is forecasted to grow at a compound annual growth rate of 4.09 percent between 2018 and 2022, according to a Technavio report.

Here are three things to know:

1. A growing geriatric population will propel the market.

2. A key market trend is the increasing adoption of minimally invasive surgical procedures.

3. Key vendors include:

  • Alphatec Spine
  • Globus Medical
  • Medtronic
  • NuVasive

More articles on biologics:

DiscGenics treats 1st patient in degenerative disc disease clinical trial: 5 things to know

3 things to know about Organogenesis

Study: Single-injection durolane hylauronic acid safe, effective treatment for knee osteoarthritis

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months